1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Targeted Therapeutics Market

Targeted Therapeutics Market

  • October 2021
  • 156 pages
  • ID: 6173683
  • Format: PDF
  • BCC Research


Table of Contents

Report Scope:
The scope of this study entails the worldwide market for targeted therapeutics.The report covers the entire market for targeted therapeutics, which incorporates two main types, small molecules and monoclonal antibodies.

Based on application, targeted therapeutics is divided into lung cancer, breast cancer, blood cancer, colorectal cancer and others.

By geography, the market has been divided into four regions: North America, Europe, Asia-Pacific and the Rest of the World. Detailed analyses of major countries: the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered. For market estimates, data has been provided for the year 2020 as the base year, with forecasts for 2021-2026. Estimated values are based on drug manufacturer total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:
- 24 data tables and 29 additional tables
- An overview of the global market for targeted therapeutics within the biopharmaceuticals sector
- Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation of current market size and market forecast for targeted therapeutics, technological advancements, and corresponding market share analysis by type, application and geographic region
- Detailed description of the target-specific functionality, advantages of target therapeutics, their production and processes, and discussion on their ability to provide therapeutic treatments for various chronic diseases
- Coverage of disease and economic burden of cancer, types of cancer therapy and insights into cancer treatment strategy timeline
- Insight into global R&D activities related to oncology drugs, industry structure, product launches, clinical trials, and regulatory scenario affecting the future marketplace
- Competitive landscape and pipeline analysis of the key companies operating in the global market, their company share analysis, and relevant oncology drug licensing deals and M&A deals
- Company profiles of major industry players, including Amgen Inc., AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb (BMS), F. Hoffmann-La Roche Ltd., Pfizer, Novartis, Merck & Co., and Takeda Pharmaceutical Co., Ltd.

Cancer was the leading cause of death in 2020, accounting for 10 million deaths, globally.This disease includes multi gene mutations that produce altered proteins controlling the signaling pathway of cells.

Usually, proteins encoded by these genes control cell growth, apoptosis, DNA repair, division and checkpoint, creating cancerous cells. But changes in these genes produce altered proteins that enable cancer.

Targeted therapeutics is an emerging and promising approach for oncology treatment, targeting the proteins that stimulate the growth of cancer cells. Small molecules offer more advantages than monoclonal antibodies, targeting molecules inside the cells (along with surface receptors) to modulate protein function.
The dynamic field of cancer R&D offers specialization in targeted therapies, which play a crucial role as mediators in cancer and other diseases, modulating diverse cellular activities.

The market for targeted therapeutics has increasing demand. As the field of targeted therapy matures, market leaders must use technologies and methods for novel targets and therapeutic approaches.

Market Size and Evolution

The global targeted therapeutics market was valued at around REDACTED in 2020 and is expected to reach REDACTED by 2026.

The United States led the market for targeted therapeutics with around REDACTED in sales in 2020. The U.S. market for targeted therapeutics is expected to increase at a CAGR of REDACTED from 2021-2026. The Asia-Pacific region generated nearly REDACTED in sales in 2020 and is expected to grow with the second highest CAGR REDACTED during the forecast period. The Rest of the World market segment revenue in 2020 was REDACTED and will grow slowly in the coming years. The European market for targeted therapeutics was worth REDACTED in 2020 and will reach REDACTED in 2026. It is forecast to increase at a CAGR of REDACTED through 2026.

Emerging markets, particularly in the Asia-Pacific region, have shown growth potential in recent years.Rising affluence in these countries brings change in lifestyles, resulting in increased incidence of cancer.

Developing countries in Africa and elsewhere are still battling some of the highest proportions of immune-mediated diseases. The need for affordable and innovative medicines drives growth in the targeted therapeutics market in the low- and middle-income developing countries.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Human Microbiome Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

  • $ 4250
  • November 2021
  • 125 pages

The global human microbiome market is expected to register a CAGR of nearly 17% over the forecast period. In recent times, the human microbiome has become an area of interest because of its association ...

  • World
  • Therapy
  • Industry analysis
  • Overweight Prevalence
  • Elderly Population


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on